Canadian National Railway reports Q2 results today against a backdrop of steady insider buying and a stock that has climbed 14% in a month — well ahead of most rail peers.
The insider story is the clearest signal heading into the print. Board chair Shauneen Bruder bought 530 shares on June 25 at around C$170, adding to a purchase she made in March. Independent director Albert Monaco bought 7,400 shares in March for roughly C$732,000 — the largest single insider transaction in the trailing 90 days. A second director added 500 shares in late April. Net insider buying over the past 90 days totals around 1,400 shares, a modest but consistent cluster of purchases that stretches from early spring through late June. The pattern suggests board-level conviction in the stock at progressively higher prices.
The lending market tells a quiet story. Borrow demand is negligible — short interest is less than 0.5% of the free float, and availability is so loose that 394 million shares remain available against fewer than 3 million borrowed. Cost to borrow has fallen 40% over the past week to just 0.42%. That is not a market pricing in meaningful downside risk. The short score also drifted lower this week, from 28.3 to 27.4, consistent with a stock where bearish conviction is fading rather than building.
The bull case rests on operational leverage as volumes recover. The stock scores in the 85th percentile on short interest rank — meaning conviction from bears is unusually low — and the dividend score ranks in the 77th percentile. EPS momentum over both 30 and 90 days sits above the midpoint of the universe. Bears would point to valuation: the P/E has expanded to 21.3x, up more than 1.6 points over the past month, while the EV/EBITDA of 14.3x and price-to-book of 5.0x leave limited room for disappointment. The analyst consensus price target of C$177.79 actually sits below Thursday's close of C$183.92 — a rare setup where the stock has run through Street consensus. Closest peer gained only 1.1% on the week versus CNR's 2.1%, and and were essentially flat on the day, underscoring how much CNR has outperformed the group recently.
Past prints have been a consistent source of near-term pressure: the last two earnings releases each produced a 3% decline on the day. Today's report will test whether the 14% monthly rally has priced in enough of the recovery — or whether the stock has moved too far ahead of the numbers for the consensus to catch up.
See the live data behind this article on ORTEX.
Open CNR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.